PRODUCTION OF CHIRAL AMINOALCHOLS

Information

  • Research Project
  • 6070479
  • ApplicationId
    6070479
  • Core Project Number
    R43GM060822
  • Full Project Number
    1R43GM060822-01
  • Serial Number
    60822
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/1/2000 - 25 years ago
  • Project End Date
    7/31/2000 - 24 years ago
  • Program Officer Name
    IKEDA, RICHARD A.
  • Budget Start Date
    2/1/2000 - 25 years ago
  • Budget End Date
    7/31/2000 - 24 years ago
  • Fiscal Year
    2000
  • Support Year
    1
  • Suffix
  • Award Notice Date
    1/14/2000 - 25 years ago
Organizations

PRODUCTION OF CHIRAL AMINOALCHOLS

Chiral vicinal aminoalcohols are important intermediates in the synthesis of many important pharmaceutical compounds. However, their synthesis remains a significant synthetic challenge. Gaining control over the stereochemistry of chiral centers at carbons bearing both the alcohol and amino groups at reasonable cost is the key to the successful production of these important chemical intermediates. Currently, no broadly-applicable route exists for the production of chiral vicinal aminoalcohols in high yield and with high stereochemical purity. The proposed research will develop a general method for the production of chiral vicinal aminoalcohols that relies on a stereoselective alcohol dehydrogenase-catalyzed conversion to introduce two chiral centers in a single step, with high yield and stereoselectivity. In preliminary work with whole cells, it has been shown that multiple enzyme systems present give rise to competing reactions that lower stereochemical purity. The use of an isolated dehydrogenase offers the potential to produce any single diastereomer in high stereochemical purity. The economics of this method depend upon efficient cofactor recycling. In Phase 1 we plan to establish the feasibility of a reaction using a stereoselective alcohol dehydrogenase coupled with formate dehydrogenase for cofactor recycling, laying the foundation for the production a variety of chiral vicinal aminoalcohols. PROPOSED COMMERCIAL APPLICATIONS: Production of key intermediates for existing and new pharmaceutical products

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    142000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:142000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOCATALYTICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    PASADENA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    91106
  • Organization District
    UNITED STATES